Home » JOHNSON & JOHNSON COMPLETES ACQUISITION OF PENINSULA
JOHNSON & JOHNSON COMPLETES ACQUISITION OF PENINSULA
Johnson & Johnson announced that its Ortho-McNeil Pharmaceutical subsidiary completed its planned acquisition of Peninsula Pharmaceuticals, a privately-held biopharmaceutical company focused on developing and commercializing antibiotics to treat life-threatening infections. The transaction was announced previously on April 19, 2005.
DrugNewswire (http://www.drugnewswire.com/885/)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May